Animal studies involving surgically severed tendons show measurable improvements in tensile strength and structural integrity following BPC-157 administration
Week 1-2: 50 mg daily to assess GI tolerance, energy changes, and side effects
These statements have not been evaluated by the FDA.
Sam Rhee: Oh, so she had it injected directly into the knee area
A GLOW peptide with COA support gives customers a clearer route to review available product information
BPC-157: NO system modulation, VEGF/FGF-2 upregulation, FAK-paxillin pathway, gastric juice stability GHK-Cu: Cu2+-dependent gene regulation (~4,000 genes), TGF-beta signaling, collagen/decorin synthesis, SOD/catalase induction BPC-157: No metal cofactor required activity is sequence-dependent GHK-Cu: Copper stoichiometry (1:1) is essential apo-GHK shows reduced bioactivity BPC-157 Research Areas: Gut & Tendon Studies The majority of BPC-157 research originates from a single laboratory group (Sikiric et al., University of Zagreb), which has published extensively on its effects in rodent models
